9-(3-hydroxy-3-methyl-2-oxobutoxy)-6H-[1,3]dioxolo[4,5-g]chromen-6-one

ID: ALA3116091

PubChem CID: 76321600

Max Phase: Preclinical

Molecular Formula: C15H14O7

Molecular Weight: 306.27

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CC(C)(O)C(=O)COc1c2c(cc3oc(=O)ccc13)OCO2

Standard InChI:  InChI=1S/C15H14O7/c1-15(2,18)11(16)6-19-13-8-3-4-12(17)22-9(8)5-10-14(13)21-7-20-10/h3-5,18H,6-7H2,1-2H3

Standard InChI Key:  ILIBQXWLXBNMBF-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 22 24  0  0  0  0  0  0  0  0999 V2000
   16.1478  -17.9655    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8564  -18.3708    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8572  -19.1898    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.5657  -19.5969    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   18.2740  -19.1860    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.2692  -18.3639    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.5601  -17.9606    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.9833  -19.5919    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.1453  -17.1483    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.1496  -19.6029    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4379  -19.1947    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4382  -18.3774    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.6610  -18.1245    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.1802  -18.7855    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.6604  -19.4469    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.4364  -16.7419    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4340  -15.9247    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7251  -15.5182    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.1405  -15.5140    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8494  -15.9204    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.1380  -14.6968    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8432  -15.0974    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
 10  3  2  0
  2  1  2  0
  1 12  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  2  1  0
  5  8  2  0
  1  9  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 11  1  0
  9 16  1  0
 16 17  1  0
 17 18  2  0
 17 19  1  0
 19 20  1  0
 19 21  1  0
 19 22  1  0
M  END

Associated Targets(non-human)

polA Taq polymerase 1 (482 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: YesOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 306.27Molecular Weight (Monoisotopic): 306.0740AlogP: 1.24#Rotatable Bonds: 4
Polar Surface Area: 95.20Molecular Species: NEUTRALHBA: 7HBD: 1
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 13.47CX Basic pKa: CX LogP: 1.24CX LogD: 1.24
Aromatic Rings: 2Heavy Atoms: 22QED Weighted: 0.85Np Likeness Score: 0.93

References

1. Garro Hugo A, Manzur Jimena M, Ciuffo Gladys M, Tonn Carlos E, Pungitore Carlos R..  (2014)  Inhibition of reverse transcriptase and Taq DNA polymerase by compounds possessing the coumarin framework.,  24  (3): [PMID:24418776] [10.1016/j.bmcl.2013.12.104]

Source